CONTACTS

Thank you for your interest in the Department of Autism Research at ANTIBIOSTRESS CLINICS and the FIAP® Precision High-Tech Care Centre.

We welcome inquiries related to autism research, FIAP® scientific frameworks, manuscript development, pilot studies, clinical translation, FIAP®-Digital, and potential scientific or technological collaborations.

For research, academic, clinical, or technological collaboration inquiries, please contact:

Dr Yves Fuamba
Founder & CEO, FIAP® Precision High-Tech Care Centre
Department of Autism Research / ANTIBIOSTRESS CLINICS

Email: yves.fuamba@antibiostress.ca
Secondary email: Yves.fuamba@fiap.ca

You may contact the Department regarding:

• FIAP® Framework; 
• Biological Burden Index — BBI; 
• Therapeutic Engagement Index — TEI; 
• FIAP®-Digital; 
• autism precision research; 
• translational stratification; 
• pilot studies and validation; 
• clinical translation; 
• responsible AI in autism care; 
• academic or institutional collaboration; 
• manuscript and publication inquiries; 
• partnership opportunities. 

The Department welcomes inquiries from:

• researchers; 
• clinicians; 
• universities; 
• research institutes; 
• hospitals and clinics; 
• digital health specialists; 
• artificial intelligence experts; 
• software developers; 
• biomarker laboratories; 
• ethics and governance specialists; 
• autism service organizations; 
• community partners. 

Please include a brief description of your area of expertise, institution or organization, and the nature of the proposed collaboration.

Families, caregivers, and community members may contact the Department for general information about the research vision of the FIAP® ECOSYSTEM.

Please note that information presented on this website is for scientific and educational purposes and should not replace individualized medical, psychological, developmental, or therapeutic advice from qualified professionals.

The FIAP® ecosystem, including BBI, TEI, adaptive neurodevelopmental window accessibility, energetic capacity, neuroplastic capacity, and FIAP®-Digital, is currently being developed as a scientific and translational research framework.

These constructs and tools should not be interpreted as established diagnostic instruments, validated treatment algorithms, or substitutes for professional clinical judgment unless and until appropriate validation and implementation processes have been completed.

The Department of Autism Research welcomes scientific, clinical, technological, and community-oriented inquiries that support the responsible development of the FIAP® ECOSYSTEM and future precision autism research.